Ascend Wellness Holdings, Inc. (AAWH)
AAWH is quoted over the counter, not listed on an exchange. Ascend Wellness Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | AAWH, quoted over the counter |
| SEC CIK | 0001756390 |
| OTC Markets tier | OTCQX (price source, 2026-11-13) |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Business address | Rochelle Park, NJ |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $63.6M cash; operating cash flow $6.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 203,421,675 (2026-11-10). | Cover page 2026-11-10 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2025-12-19 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | WithumSmith+Brown, PC, New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-03-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $130.0M | -$28.0M | $5.4M | $63.6M | $338.3M | $493.6M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $126.1M | -$9.8M | $22.5M | $67.0M | $334.4M | $488.3M | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $116.9M | -$29.5M | -$19.4M | $60.9M | $318.9M | $489.5M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $120.5M | -$48.7M | $16.3M | $85.7M | $319.5M | $500.6M | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | $124.7M | -$25.8M | -$2.0M | $87.3M | $369.1M | $516.0M | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $127.3M | -$24.4M | $17.8M | $95.3M | $349.6M | $533.0M | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $128.0M | -$19.3M | $5.9M | $100.0M | $333.0M | $547.2M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $136.0M | -$16.8M | $35.2M | $88.3M | $308.0M | $561.6M | 10-K 2026-03-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-12-19 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEFA14A | 2026-08-10 |
Source: SEC EDGAR submissions feed, 149 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier